Nanjing Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Retailing
  • ISIN: CNE000000KV1
CNY
5.35
0.05 (0.94%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
13,843.78
13,828.14
13,167.73
13,720.53
14,246.88
12,757.99
13,706.07
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
13,843.78
13,828.14
13,167.73
13,720.53
14,246.88
12,757.99
13,706.07
Raw Material Cost
12,974.41
12,955.15
12,437.10
12,980.63
13,462.57
11,975.32
12,928.45
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
64.81
88.66
75.37
75.52
69.47
59.31
95.99
Selling and Distribution Expenses
452.54
513.89
409.40
356.03
368.26
380.01
393.04
Other Expenses
-5.72
-6.78
-6.80
-6.79
-6.21
-5.92
-8.77
Total Expenditure (Excl Depreciation)
13,434.56
13,489.92
12,853.92
13,344.25
13,838.19
12,355.43
13,329.73
Operating Profit (PBDIT) excl Other Income
409.20000000000005
338.2
313.8
376.3
408.7
402.59999999999997
376.3
Other Income
-33.67
250.77
-27.52
-11.98
-36.13
-54.85
-31.17
Operating Profit (PBDIT)
348.55
620.84
330.85
401.82
419.23
369.24
386.04
Interest
64.81
88.66
75.37
75.52
69.47
59.31
95.99
Exceptional Items
0.20
-9.54
0.51
0.03
0.35
0.00
0.00
Gross Profit (PBDT)
869.37
872.99
730.63
739.90
784.31
782.68
777.62
Depreciation
0.00
74.62
74.62
73.27
73.27
68.61
68.61
Profit Before Tax
283.93
448.03
181.37
253.06
276.85
241.32
221.44
Tax
70.22
146.17
31.69
86.35
60.75
61.53
55.41
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
174.57
222.86
110.69
113.92
177.36
128.75
130.56
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
174.57
222.86
110.69
113.92
177.36
128.75
130.56
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
37.13
80.05
39.31
50.25
38.22
50.57
35.70
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
211.70
302.91
150.01
164.17
215.58
179.31
166.26
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
7,357.58
7,178.38
6,967.49
6,852.90
7,018.68
6,829.09
6,712.27
Earnings per share (EPS)
0.12
0.15
0.08
0.06
0.14
0.1
0.1
Diluted Earnings per share
0.12
0.15
0.08
0.06
0.14
0.1
0.1
Operating Profit Margin (Excl OI)
2.76%
2.14%
2.15%
2.48%
2.68%
2.79%
2.54%
Gross Profit Margin
2.05%
3.78%
1.94%
2.38%
2.46%
2.43%
2.12%
PAT Margin
1.26%
1.61%
0.84%
0.83%
1.24%
1.01%
0.95%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 0.11% vs 5.02% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is -30.11% vs 101.93% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 3.27% vs 3.26% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -26.94% vs 17.64% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Nanjing Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
13,843.78
0
13,843.78
Other Operating Income
0.00
0.00
0.00
Total Operating income
13,843.78
0
13,843.78
Raw Material Cost
12,974.41
0
12,974.41
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
64.81
0
64.81
Selling and Distribution Expenses
452.54
0
452.54
Other Expenses
-5.72
0.00
-5.72
Total Expenditure (Excl Depreciation)
13,434.56
0
13,434.56
Operating Profit (PBDIT) excl Other Income
409.22
0.00
409.22
Other Income
-33.67
0
-33.67
Operating Profit (PBDIT)
348.55
0
348.55
Interest
64.81
0
64.81
Exceptional Items
0.20
0
0.20
Gross Profit (PBDT)
869.37
0
869.37
Depreciation
0.00
0
0.00
Profit Before Tax
283.93
0
283.93
Tax
70.22
0
70.22
Provisions and contingencies
0
0
0.00
Profit After Tax
174.57
0
174.57
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
174.57
0
174.57
Share in Profit of Associates
0
0
0.00
Minority Interest
37.13
0
37.13
Other related items
0.00
0.00
0.00
Consolidated Net Profit
211.70
0
211.70
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
7,357.58
0
7,357.58
Earnings per share (EPS)
0.12
0
0.12
Diluted Earnings per share
0.12
0
0.12
Operating Profit Margin (Excl OI)
2.76%
0%
0.00
2.76%
Gross Profit Margin
2.05%
0%
0.00
2.05%
PAT Margin
1.26%
0%
0.00
1.26%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,384.38 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 0.11% vs 5.02% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -2.83% vs 2.11% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 21.17 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -30.11% vs 101.93% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -1.81% vs 9.50% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 38.22 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 3.27% vs 3.26% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -16.07% vs -0.02% in Mar 2025

Quarterly - Interest
Interest 6.48 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -26.94% vs 17.64% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -6.76% vs -21.73% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.76%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025